Skip to main navigation Skip to search Skip to main content

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): An open-label, randomised, multicentre phase 2 trial

  • Kris V. Kowdley
  • , Eric Lawitz
  • , Israel Crespo
  • , Tarek Hassanein
  • , Mitchell N. Davis
  • , Michael Demicco
  • , David E. Bernstein
  • , Nezam Afdhal
  • , John M. Vierling
  • , Stuart C. Gordon
  • , Jane K. Anderson
  • , Robert H. Hyland
  • , Hadas Dvory-Sobol
  • , Di An
  • , Robert G. Hindes
  • , Efsevia Albanis
  • , William T. Symonds
  • , M. Michelle Berrey
  • , David R. Nelson
  • , Ira M. Jacobson

Research output: Contribution to journal › Article › peer-review

255 Scopus citations

Fingerprint

Dive into the research topics of 'Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): An open-label, randomised, multicentre phase 2 trial'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology